Results

Total Results: 2,080 records

Showing results for "drug".

1801. Technical-Brief-31-Mobile-Health-Applications-For-Self-Management-Of-Diabetes (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt.pdf
      May 01, 2018 - Some connect directly to US Food and Drug Administration (FDA)-approved medical devices, such as blood … transfer, license, and/or covey some or all the information collected on the platform including drug … Food and Drug Administration. … Food and Drug Administration. Letter to WellDoc regarding BlueStar 510(k) clearance. 2017.

1802. genetic-testing-developmental-disabilities-protocol-140930 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/genetic-testing-developmental-disabilities_research-protocol.pdf
      September 30, 2014 - Food and Drug Administration (FDA) or as a laboratory-developed test (LDT).20,21 FDA-cleared or -approved … Food and Drug Administration; LDT—laboratory-developed test Source: www.effectivehealthcare.ahrq.gov

1803. Opioid Abuse and Addiction | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/opioid-abuse-and-addiction
      February 12, 2019 - Treatment of Acute Pain: An Evidence Map Research Protocol February 12, 2019 Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder Rapid Evidence Product August 21, 2020 Prevention, Diagnosis, and Management of Opioids, Opioid Mis…

1804. Topic Brief: Rehabilitation Options for Post-acute Care Diagnoses (pdf file)
      effectivehealthcare.ahrq.gov/system/files/docs/rehab_options_pac_diagnoses_topic_brief.pdf
      October 28, 2020 - Does the nomination represent a health care drug, intervention, device, technology, or health care

1805. Topic Brief: Radiation Therapy for Bone Metastases (pdf file)
      effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-radiation-therapy-bone-metastases.pdf
      August 01, 2022 - Does the nomination represent a health care drug, intervention, device, technology, or health care

1806. Smoking-Pregnancy-Infants Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_executive.pdf
      February 01, 2014 - Food and Drug Administration places the transdermal nicotine patch in pregnancy category D, which indicates

1807. Glaucoma-Treatment-Appendices-11-5-10-2 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
      October 27, 2009 - Confidence interval COAG Chronic open angle glaucoma EPC Evidence-based Practice Center FDA Food and Drug

1808. Research White Paper - EPC Response to IOM Standards for Systematic Reviews (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/iom-standards_white-paper.pdf
      April 01, 2013 - They additionally conferred with experts at the Drug Effectiveness Review Project, the Emergency Care … Food and Drug Administration; IOM = Institute of Medicine; PICOTS = populations, interventions, comparators

1809. Identifying Priorities for Patient-Centered Outcomes Research for Serious Mental Illness (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-priorities_research.pdf
      September 01, 2011 - Washington University Director, Center for Cross Cultural Psychology Laughren, Thomas P., MD Food and Drug

1810. Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
      April 25, 2013 - The broad AHRQ conclusion also stands in contrast to conclusions drawn by the Food and Drug Administration

1811. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
      September 01, 2011 - In that study, the authors reported a significant difference in relapse rates favoring active drug ( … www.effectivehealthcare.ahrq.gov 29 early adverse events responded better to the form of CBT tested than to any drug

1812. Disposition of Comments for CER 152 Nonmetastatic Muscle-Invasive Bladder Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_disposition-comments.pdf
      June 30, 2015 - Better to say cisplatin based multi-drug regimens such as GC and MVAC.

1813. Autism Spectrum Disorder — An Update | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/autism-update/research-protocol
      September 20, 2013 - Food and Drug Administration (FDA) to treat irritability in children 5 to 16 years of age with ASD. 48

1814. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
      May 27, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: May 27, 2010 1 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Comparative Effectiveness and Safety of Radio…

1815. Undescended-Testicle Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
      December 01, 2012 - studies is possibly due to heterogeneity in the study populations or potentially due to variability in drug

1816. Technical Brief Disposition of Comments Report for Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
      December 14, 2012 - therapy (across multiple effective regimens) versus prediction of benefit from a specific regimen or drug

1817. Web Interactive Presentation of EPC Reports: A Foray Into Interactive Reports (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-web-interactive-presentation.pdf
      September 01, 2019 - applicable, number of arms, parallel or crossover), their sample size, the intervention intensity (e.g., drug

1818. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
      September 01, 2011 - Layout 1 Background Major depressive disorder (MDD) is common and costly. Over the course of a year, between 13.1 million and 14.2 million people will experience MDD. Approximately half of these people seek help for this condition, and only 20 percent of those receive adequate treatment. For those who do initiate tr…

1819. Meditation Programs for Stress and Well-Being | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/meditation/research-protocol
      October 17, 2012 - Current Page Topic Timeline Nov. 8, 2010 Topic Suggestion Oct. 17, 2012 Research Protocol Jan. 6, 2014 Systematic Review Apr. 9, 2014 Disposition of Comments Report Meditation Programs for Stress and Well-Being Research Protocol Archived October 17, 2012 Download Main Document PDF 180.4 KB On October…

1820. Use of and access to health care by Medicare beneficiaries with diabetes: impact of diabetes type and insulin use, 2007-2011 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-medicare-use_research.pdf
      January 01, 2014 - Use of and access to health care by Medicare beneficiaries with diabetes: impact of diabetes type and insulin use, 2007-2011 Use of and access to health care by Medicare beneficiaries with diabetes: impact of diabetes type and insulin use, 2007-2011 Use of Diabetes Care Data Points # 18 In 2011, about 25 percent o…